Abstract
Objective The Multidimensional Assessment of Parenting Scale (MAPS) was developed to assess a wide range of behaviors across positive and negative domains of parenting. This study aims to expand the utility of the MAPS by evaluating a youth-report version which provides an additional perspective on parenting practices.
Method The study evaluated the youth-report form of the MAPS (MAPS-Y) in a large clinical population (N = 628) ranging from middle childhood (8-12) to adolescence (13-17) who were admitted to partial and inpatient psychiatric units. Youth and their caregivers completed the parent and youth versions of the MAPS questionnaire, and measures of child and adolescent psychopathology, emotion regulation, family context, and adversity. Analyses of factor structure, reliability, agreement, and validity were performed. The study also examined a short form of the MAPS-Y for reliability and validity.
Results CFA and model fit indices indicated that all items loaded as expected onto subscales and with good fit. Analyses support strong reliability. The factor structure of the youth-report was invariant across developmental stages, included both positive and negative domains, and demonstrated strong psychometric properties. The MAPS-Y short form demonstrated strong validity and reliability.
Conclusion The youth-report of the MAPS and its short form are appropriate for use among children and adolescents experiencing acute clinical symptoms. The MAPS youth-report will allow for nuanced, in-depth assessment of the parenting behaviors beyond parent-report that are critical to treatment outcomes in youth.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The last author was supported by NICHD (L40HD103048), and by the Bradley Hospital COBRE Center for Sleep and Circadian Rhythms in Child and Adolescent Mental Health (P20GM139743).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Lifespan Hospital Institutional Review Board approved the study as a retrospective chart review, and the measures were administered to inform clinical care in inpatient and partial hospitalization programs.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos